|
|
- 2018
新基因FAM172A对人脐静脉内皮细胞增殖和凋亡的影响
|
Abstract:
摘要 目的 观察新基因FAM172A对内皮细胞增殖、凋亡的影响,探索FAM172A在动脉粥样硬化发生发展中的作用.方法 体外培养人脐静脉内皮细胞HUVEC,构建FAM172A真核表达载体pcDNA3.1(-)-FAM172A,利用脂质体转染重组质粒pcDNA3.1/myc-His(-)-FAM172A于HUVEC,使其高表达FAM172A;合成靶向干扰FAMA172A表达的siRNA,利用脂质体3000转染siRNA,使其低表达FAM172A;RT-qPCR和蛋白免疫印迹检测转染效果;使用CCK-8及EdU细胞增殖检测法检测FAM172A对HUVEC增殖的影响;使用流式细胞仪检测FAM172A对HUVEC细胞凋亡的影响;RT-qPCR、蛋白免疫印迹检测FAM172A对NF-κB表达的影响.结果 RT-qPCR及Western转染效率检测结果显示,重组质粒组FAM172A的mRNA是空白质粒组的33.966倍,蛋白表达是其2.772倍,4组siRNA干扰效率相比,siRNA1162干扰效率最高,FAM172A的mRNA表达降低69.67%,FAM172A蛋白表达降低73.8%;CCK-8与EdU细胞增殖实验结果显示新基因FAM172A抑制HUVEC的增殖,与空白质粒组相比,转染24、48、72 h后重组质粒组细胞在450nm波长处吸光度A450值降低,细胞增殖率降低,相反,靶向干扰基因FAM172A的表达后,A450值升高,细胞增殖率升高.流式细胞技术细胞凋亡检测结果显示新基因FAM172A促进HUVEC凋亡,与空白质粒组相比,转染重组质粒组Annexin V 阳性比增加;靶向干扰基因FAM172A的表达后,Annexin V 阳性比降低.RT-qPCR和Western blot结果显示,与转染空白质粒组相比,转染FAM172A重组质粒组,NF-κBp65表达增高(2.033∶1.050);与干扰对照组相比,干扰FAM172A表达时,NF-κBp65表达降低(0.366∶0.996).结论 新基因FAM172A能够抑制人脐静脉内皮细胞的增殖,促进细胞凋亡,其可能通过NF-κB通路参与调控人脐静脉内皮细胞增殖和凋亡的.
| [1] | GOEBELER M, GILLITZER R, KILIAN K, et al.Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells[J].Blood,2001, 97(1): 46-55. |
| [2] | HANSSON G K.Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005, 352(16):1685-1695. |
| [3] | PARAVICINI T M, TOUYZ R M.NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities[J]. Diabetes Care, 2008, 31(Suppl 2):S170-180. |
| [4] | SINGH U, JIALAL I.Oxidative stress and atherosclerosis[J]. Pathophysiology, 2006, 13(3): 129-142. |
| [5] | 李连喜, 陶征, 董雪红, 等.C5orf21基因的分子克隆及在糖尿病大血管病变中的作用[J].中华医学杂志, 2009, 89(36): 2574-2577. |
| [6] | LI L X, TAO Z, DONG X H, et al.Molecular cloning of a novel gene, C5orf21 gene and its roles in diabetic macroangiopathy[J]. National Medical Journal of China, 2009, 89(36): 2574-2577. |
| [7] | LI L, DONG X, LEONG M C, et al.Identification of the novel protein FAM172A, and its up-regulation by high glucose in human aorticsmooth muscle cells[J]. Int J Mol Med, 2010, 26(4): 483-490. |
| [8] | 李连喜, 周闻白, 陶征, 等. FAM172A蛋白对人胚胎肾细胞凋亡及增殖的影响[J].中华医学杂志,2010, 90(34): 2424-2427. |
| [9] | LI L X, ZHOU W B, TAO Z, et al.Effect of FAM172A protein on apoptosis and proliferation in HEK293 cells[J].National Medical Journal of China, 2010, 90(34): 2424-2427. |
| [10] | 张仁雯, 康艳芳, 乔雍, 等. FAM172A及其异构体重组蛋白对体外培养肝细胞增殖的影响[J]. 中华实验和临床感染病杂志,2013, 7(3): 1-5. |
| [11] | ZHANG R W, KANG Y F, QIAO Y, et al.Effects of FAM172A Protein on Apoptosis and Proliferation of Human Embryonic Renal Cells[J]. Chinese Journal of Experimental and Clinical Infectious Diseases,2013, 7(3): 1-5. |
| [12] | LIU H F, QI X W, MA L L, et al.Atorvastatin improves endothelial progenitor cell function and reduces pulmonary hypertension in patients with chronic pulmonary heart disease[J]. Exp Clin Cardiol, 2013, 18(1): e40-e43. |
| [13] | BAI X, WANG X, XU Q.Endothelial damage and stem cell repair in atherosclerosis[J]. Vascul Pharmacal, 2010, 52(5):224-229. |
| [14] | GHOSH S, MAY M J, KOOP E B.NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses[J]. Anna Rev Immunol, 1998, 16(1): 225-260. |
| [15] | LUO,KAMATA H, KARIN M.IKK/NF-kappaB signaling: balancing life and death: a new approach to cancer therapy[J]. J Clin Invest, 2005, 115(10): 2625-2632. |
| [16] | SHISHODIA S, AGGARWAL B B.Nuclear factor-kappaB activation: a question of life or death[J]. J Biochem Mol Biol, 2002, 35(1): 28-40. |
| [17] | MENG G, LIU Y, LOU C, et al.Emodin suppresses lipopolysaccharide-induced pro-inflammatory responses and NF-kappaB activation by disrupting lipid rafts in CD14-negative endothelial cells[J]. Br J Pharmacol, 2010, 161(7): 1628-1644. |
| [18] | ZENG X K, GUAN Y F, REMICK D G, et al.Signal pathways underlying homocysteine-induced production of MCP-1 and IL-8 in cultured human whole blood[J]. Acta Pharmacol Sin, 2005, 26(1): 85-91. |
| [19] | FENG Z, LI H, LIU S, et al.FAM172A induces S phase arrest of HepG2 cells via Notch 3[J].Oncol Rep, 2013, 29(3): 1154-1160. |
| [20] | CUI C, YE L, HUANG Z.et al.FAM172A is a tumor suppressor in colorectal carcinoma[J]. Tumour Biol,2016, 37(5): 6501-6510. |
| [21] | QIAN K, ZHANG J, Lu J, et al.FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoter[J].Oncol Rep, 2016, 35(3): 1273-1280. |
| [22] | LI M F, ZHANG R, GUO M G, et al.FAM172A protein promotes the proliferation of human papillary thyroid carcinoma cells via the p38 mitogen-activated protein kinase pathway[J]. Mol Med Rep, 2016, 13(1): 353-358. |
| [23] | HIPP M S, URBICH C, MAYER P, et al.Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1[J]. Eur J Immunol, 2002, 32(8): 2208-2217. |
